Therapies

New generation intraocular lenses (IOLs) are changing the game for patients seeking more spectacle independence, with reduced visual disturbances. Insight...

Recent study results have provided real-world evidence supporting the effectiveness, tolerability, and safety profile of Ikervis, a 0.1% ciclosporin eye...

US biopharmaceutical company Iveric Bio has released new data for its avacincaptad pegol (ACP) therapy for geographic atrophy (GA), which...

  Rayner, the pioneering manufacturer and supplier of ophthalmic solutions for cataract and refractive surgery, has announced the launch of...

At the completion of this article, the reader should be able to improve their management of patients with glaucoma. Including:...

At the completion of this article, the reader should be able to improve their glaucoma management. Including: • Understand the...

Four international experts provide guidance in a series of clinically-relevant perspectives on dry eye disease treatment procedures in Issue 70...

Specsavers has hit a major milestone in its efforts to find undetected glaucoma in Australia, ensuring patients now have more...

Glaucoma specialist and medical geneticist DR JANEY WIGGS revealed two new genes in juvenile early-onset glaucoma and dissected the value...

With the average life expectancy at initial glaucoma diagnosis being up to 13 years, patients require a sustainable first line...